J9325 HCPCS Level II code: Injection, talimogene laherparepvec, per 1 million plaque forming units
J9325 is the HCPCS code for “Injection, talimogene laherparepvec, per 1 million plaque forming units” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9325Injection, talimogene laherparepvec, per 1 million plaque forming units
Short description: Inj talimogene laherparepvec
HCPCS · United States
Medicare details
The indicators CMS publishes with J9325 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2017
Where J9325 sits
- 1J codesDrugs administered other than orally
- 2Active code J9325Injection, talimogene laherparepvec, per 1 million plaque forming units
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9325 mean?
J9325 is the HCPCS code for “Injection, talimogene laherparepvec, per 1 million plaque forming units” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9325?
CMS lists J9325’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9325
All J codesJ9319Injection, romidepsin, lyophilized, 0.1 mgJ9320Injection, streptozocin, 1 gramJ9321Injection, epcoritamab-bysp, 0.16 mgJ9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mgJ9323Injection, pemetrexed ditromethamine, 10 mgJ9324Injection, pemetrexed (pemrydi rtu), 10 mgJ9326Injection, telisotuzumab vedotin-tllv, 1 mgJ9328Injection, temozolomide, 1 mgJ9329Injection, tislelizumab-jsgr, 1mgJ9330Injection, temsirolimus, 1 mgJ9331Injection, sirolimus protein-bound particles, 1 mgJ9332Injection, efgartigimod alfa-fcab, 2mg